Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Meningeal Carcinomatosis 7Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Breast Neoplasms 6Burkitt Lymphoma 5Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myeloid, Acute 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplastic Cells, Circulating 2Meningeal Neoplasms 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell 2Glioblastoma 2Brain Neoplasms 2Astrocytoma 2Vomiting 1Uveal Melanoma 1Psychomotor Agitation 1Pain, Postoperative 1Oligodendroglioma 1Nevus 1Neoplasm Recurrence, Local 1Myelodysplastic Syndromes 1Meningioma 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, Follicular 1Leukemia, Monocytic, Acute 1Leukemia, Biphenotypic, Acute 1Hematopoietic and Lymphatic System Neoplasm 1

Interventions

Interviews as Topic 12Specimen Handling 9Practice Guidelines as Topic 8Standard of Care 7Educational Status 7Methods 5Early Intervention, Educational 5Patient Navigation 4Health Promotion 3Acupressure 3Telemedicine 2Restraint, Physical 2Behavior Therapy 2Aromatherapy 2theanine 1ruxolitinib 1merphos 1lavender oil 1jojoba wax 1axatilimab 1X-Rays 1Tacrolimus 1Surveys and Questionnaires 1Stem Cell Transplantation 1Spiritual Therapies 1Spinal Puncture 1Resistance Training 1Psychotherapy 1Psilocybin 1Phantoms, Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hematopoietic and Lymphatic System Neoplasm × Spinal Puncture × Clear all
NCT06895473 2026-01-30

Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome

OHSU Knight Cancer Institute

Phase 2 Recruiting
26 enrolled

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡